Journal of the College of Physicians and Surgeons Pakistan
ISSN: 1022-386X (PRINT)
ISSN: 1681-7168 (ONLINE)
Affiliations
doi: 10.29271/jcpsp.2023.10.1210
Sir,
The study by Alegre et al. is very interesting.1 The paper reported incongruent free T4 (FT4) levels in relation to the clinical conditions or/and thyroid stimulating hormone (TSH), ruling out familial dysalbuminemic hyperthyroxinemia (FDH) patients and some potential interferences, and concluded that a single alternative method may not be enough to avoid the similar analytical problem.
We fully support the above conclusion. FDH is a rare autosomal dominant genetic disorder (albumin gene variant (R218S)).2 There is a pseudo-high FT4 report on laboratory testing and an increased risk of miscarriage for FDH. Recently, we also collected a group of results of high FT4 levels in a 33-year female. Although the test results from the Beckman Coulter and Roche measurement systems showed that FT4 was high (Table I), there was no evidence of abnormal thyroid function. The woman had been trying to conceive without any treatment and drugs. However, there was a normal value of FT4 from the measurement system of Mindray (CL-6000i) for the same patient (Table I).
Table I: The different levels of FT4 for the female patient.
Date |
TSH (mIU/L) |
FT3 (pmol/L) |
FT4 (pmol/L) |
Measurement |
Reference |
2022/9/22 |
3.28 |
5.44 |
18.39 |
Mindray CL-6000i |
TSH: from 0.35 to FT3: from 2.43 to FT4: from 9.30 to |
2022/9/9 |
5.15 |
5.31 |
24.35 |
Beckman Coulter |
TSH: from 0.34 to FT3: from 3.80 to FT4: from 7.89 to |
2022/8/19 |
4.74 |
5.23 |
30.88 |
||
2022/7/29 |
3.68 |
6.37 |
37.93 |
Cobas 8000 |
TSH: from 0.27 to FT3: from 3.10 to FT4: from 12.00 to |
2022/5/23 |
3.03 |
5.87 |
33.70 |
Beckman Coulter |
TSH: from 0.34 to FT3: from 3.80 to FT4: from 7.89 to |
2021/8/24 |
3.01 |
6.47 |
20.66 |
||
2021/5/23 |
2.37 |
6.47 |
31.26 |
||
2021/5/17 |
2.66 |
6.36 |
32.15 |
||
2021/1/15 |
5.40 |
6.34 |
32.52 |
Cobas 8000 |
TSH: from 0.27 to FT3: from 3.10 to FT4: from 12.00 to |
TSH, Thyrotropin; FT3, Free triiodothyronine; FT4, Free thyroxine. |
Gene sequencing showed support for FDH diagnosis. To avoid the pseudo-high FT4 reports from a laboratory, we propose the following methods:
COMPETING INTEREST:
The authors declared no competing interest.
AUTHORS’ CONTRIBUTION:
GMZ: Designed the report and revised the manuscript.
QJZ: Collected the case data and drafted the main part of the manuscript.
All authors approved the final version of the manuscript to be published.
REFERENCES